For Tuberculosis (TB) Clinical Auxiliary Diagnosis of Recombinant Mycobacterium Tuberculosis Allergen ESAT6 - CFP10 Dose of Certain Phase IIb Clinical Research

Trial Profile

For Tuberculosis (TB) Clinical Auxiliary Diagnosis of Recombinant Mycobacterium Tuberculosis Allergen ESAT6 - CFP10 Dose of Certain Phase IIb Clinical Research

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Mar 2017

At a glance

  • Drugs Mycobacterium riyadhense (Primary) ; Tuberculin
  • Indications Tuberculosis
  • Focus Diagnostic use; Pharmacodynamics
  • Sponsors AnHui Longcom Biologic Pharmacy
  • Most Recent Events

    • 14 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 03 Mar 2015 Planned End Date changed from 1 May 2015 to 1 Jul 2015, according to ClinicalTrials.gov record.
    • 03 Mar 2015 Planned primary completion date changed from 1 Feb 2015 to 1 Apr 2015, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top